| http://www.w3.org/ns/prov#value | - The compounds of the invention may be particularly useful in the treatment of multiple myeloma, bladder, cervical, prostate and thyroid carcinomas, lung, breast, and colon cancers.In a further aspect, the present invention provides a pharmaceutical composition comprising a compound as defined herein which is capable of binding to FGFR and a therapeutically acceptable carrier.In a further aspect, t
|
